“chronic-kidney-disease” Archives

in
Entry Author Date Location
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More 09/04/20 National
FDA Rejects Tricida Chronic Kidney Disease Drug, More Data Needed 08/25/20 San Francisco
Two Days, Six IPOs, and $1B Raised for Biotech Research & More 07/17/20 National
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
Novo Nordisk Strikes a $725M Deal for AstraZeneca Spinout Corvidia 06/11/20 Boston
Reata Bags $350M as It Preps Rare Chronic Kidney Disease Drug for FDA 06/11/20 Texas
Cara Therapeutics Itching Drug Scratches Off Goals of Phase 3 Test 04/21/20 New York
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More 01/31/20 National
Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy 01/08/20 San Francisco
Bio Roundup: FDA Approvals, Intrexon’s Shift, Melinta Bankruptcy & More 01/03/20 National
Reata’s Kidney Drug Hits Goals of Key Study, Paves Way for FDA Filing 11/12/19 Texas
Alnylam Makes Case For 2nd RNAi Drug at Big Liver Disease Meeting 04/12/19 Boston
Trevi Therapeutics Files for IPO to Fund Anti-Itching Drug R&D 04/08/19 New York
IPO Wave Rolls On as Five Life Science Firms Haul In $651M 06/28/18 National
Akebia Merges With Keryx as Anemia Drug Race Nears Finish Line 06/28/18 Boston
Inozyme Gets $49M From Sanofi, Novo to Tackle Rare Infant Disease 11/15/17 Boston
Proteon Therapeutics Plans Path Forward for Blood Vessel Drug 03/16/17 Boston
Akebia Gets $265M From Otsuka to Bankroll Anemia Drug Push 12/20/16 Boston
Bio Roundup: NY Rises, Prez Inks Cures, Ophthotech Crashes & More 12/16/16 National
After Rival Stumbles, Relypsa Gets $1.5B Buyout Bid From Galenica 07/21/16 San Francisco
Big Deals in Texas (ZS Pharma, HomeAway, Gravitant) & Other News 11/09/15 Texas
Dallas-Fort Worth Aims to Boost Life Sciences Ecosystem 10/05/15 Texas
East Coast Biotech Roundup: Celgene, Blueprint(s), Intarcia & More 05/01/15 Boston
Tricida Grabs $30M Series B for Chronic Kidney Disease Treatment 03/04/15 San Francisco
West Coast Biotech Roundup: Tracon, Mirati, Third Rock, & Dendreon 02/06/15 San Diego
Akebia, Trading M&A For an IPO, Follows Fast in Anemia Drug Race 06/09/14 Boston
Relypsa Aims to Delay Need for Costly Dialysis in Kidney Patients 02/05/14 San Francisco
East Coast Biotech Roundup: Enanta, NY Disruptors, Repligen, & More 01/24/14 Boston
Celgene Partner Acceleron Files For IPO; Plans to Raise Up to $75M 08/07/13 Boston
Relypsa Gets Another $50M for Drug to Fight Excess Potassium 08/13/12 San Francisco
Page 1 of 2 next page »